Literature DB >> 7883789

Drosophila in cancer research: the first fifty tumor suppressor genes.

K L Watson1, R W Justice, P J Bryant.   

Abstract

In Drosophila, over 50 genes have been identified in which loss-of-function mutations lead to excess cell proliferation in the embryo, in the central nervous system, imaginal discs or hematopoietic organs of the larva, or in the adult gonads. Twenty-two of these genes have been cloned and characterized at the molecular level, and nine of them show clear homology to mammalian genes. Most of these mammalian genes had not been previously implicated in cell proliferation control. Overgrowth in some of the mutants involves conversion to a cell type that, in normal development, shows more cell proliferation than the original cell type. Thus the neurogenic mutants, including Notch, show conversion of epidermal cells to neuroblasts, leading to the 'neurogenic' phenotype of excess nervous tissue. The ovarian tumor mutants show conversion of the female germ line to a cell type resembling the male germ line, which undergoes more proliferation than the female germ line. Mutations of the fat locus cause hyperplastic overgrowth of imaginal discs, in which the epithelial structure is largely intact. The predicted fat protein product is a giant relative of cadherins, supporting indications from human cancer that cadherins play an important role in tumor suppression. Mutations in the lethal(2)giant larvae and lethal(1)discs large genes cause neoplastic overgrowth of imaginal discs as well as the larval brain. The dlg gene encodes a membrane-associated guanylate kinase homolog that is localized at septate junctions between epithelial cells. This protein is a member of a family of homologs that also includes two proteins found at mammalian tight junctions (ZO-1 and ZO-2) and a protein found at mammalian synaptic junctions (PSD-95/SAP90). Genes in which mutations cause blood cell overproduction include aberrant immune response-8, which encodes the RpS6 ribosomal protein and hopscotch, which encodes a putative non-receptor protein tyrosine kinase. The gene products identified by ovarian tumor mutants do not show clear amino acid sequence homology to known proteins. Drosophila provides an opportunity to rapidly identify and characterize tumor suppressor genes, many of which have mammalian homologs that might also be involved in cell proliferation control and tumor suppression.

Entities:  

Mesh:

Year:  1994        PMID: 7883789     DOI: 10.1242/jcs.1994.supplement_18.4

Source DB:  PubMed          Journal:  J Cell Sci Suppl        ISSN: 0269-3518


  33 in total

1.  Mutations in Drosophila DP and E2F distinguish G1-S progression from an associated transcriptional program.

Authors:  I Royzman; A J Whittaker; T L Orr-Weaver
Journal:  Genes Dev       Date:  1997-08-01       Impact factor: 11.361

2.  A directed screen for genes involved in Drosophila blood cell activation.

Authors:  Carl-Johan Zettervall; Ines Anderl; Michael J Williams; Ruth Palmer; Eva Kurucz; Istvan Ando; Dan Hultmark
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-20       Impact factor: 11.205

3.  Melanotic mutants in Drosophila: pathways and phenotypes.

Authors:  Svetlana Minakhina; Ruth Steward
Journal:  Genetics       Date:  2006-07-02       Impact factor: 4.562

Review 4.  Size control: cell proliferation does not equal growth.

Authors:  T T Su; P H O'Farrell
Journal:  Curr Biol       Date:  1998-09-24       Impact factor: 10.834

5.  Organizing a functional junctional complex requires specific domains of the Drosophila MAGUK Discs large.

Authors:  C D Hough; D F Woods; S Park; P J Bryant
Journal:  Genes Dev       Date:  1997-12-01       Impact factor: 11.361

6.  Identification of immune system and response genes, and novel mutations causing melanotic tumor formation in Drosophila melanogaster.

Authors:  A Rodriguez; Z Zhou; M L Tang; S Meller; J Chen; H Bellen; D A Kimbrell
Journal:  Genetics       Date:  1996-06       Impact factor: 4.562

7.  A genetic screen for dominant modifiers of a small-wing phenotype in Drosophila melanogaster identifies proteins involved in splicing and translation.

Authors:  Carmen M A Coelho; Benjamin Kolevski; Cherryl D Walker; Irene Lavagi; Thomas Shaw; Anselm Ebert; Sally J Leevers; Steven J Marygold
Journal:  Genetics       Date:  2005-07-05       Impact factor: 4.562

8.  Ribozyme-mediated targeting of IkappaBgamma inhibits melanoma invasion and metastasis.

Authors:  Sima Z Torabian; David de Semir; Mehdi Nosrati; Sepideh Bagheri; Altaf A Dar; Sylvia Fong; Yong Liu; Scot Federman; Jeff Simko; Chris Haqq; Robert J Debs; Mohammed Kashani-Sabet
Journal:  Am J Pathol       Date:  2009-01-29       Impact factor: 4.307

Review 9.  Drosophila melanogaster: a model and a tool to investigate malignancy and identify new therapeutics.

Authors:  Cayetano Gonzalez
Journal:  Nat Rev Cancer       Date:  2013-02-07       Impact factor: 60.716

10.  Lgl2 executes its function as a tumor suppressor by regulating ErbB signaling in the zebrafish epidermis.

Authors:  Sven Reischauer; Mitchell P Levesque; Christiane Nüsslein-Volhard; Mahendra Sonawane
Journal:  PLoS Genet       Date:  2009-11-13       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.